Endothelial Cell Infection and Endotheliitis in COVID-19: Insights into Vascular Involvement
Endothelial cell involvement and endotheliitis across various vascular beds emerge as key pathological features in COVID-19, shedding light on the systemic vascular effects of SARS-CoV-2 infection and potential implications for multiorgan dysfunction in affected patients.
December 2020
Contact Tracing: Strategies for Identifying and Managing Healthcare Workers Linked to COVID-19 Cases
Effective public health management of contacts, including healthcare workers, exposed to COVID-19 cases is crucial for mitigating transmission risks and containing the spread of the virus, highlighting the importance of robust contact tracing strategies in pandemic response efforts.
December 2020
COVID-19: Protecting Hospitals from Nosocomial Transmissions
Delayed diagnoses contribute to nosocomial transmissions in hospitals, emphasizing the need for improved diagnostic protocols and infection control measures to protect healthcare facilities from the invisible threat of COVID-19.
December 2020
Persistence of SARS-CoV-2 Virus in Aerosols and on Surfaces: Implications for Transmission
Examination of the persistence rates of SARS-CoV-2 in aerosols and on surfaces compared to SARS-CoV-1, shedding light on the potential routes of transmission and informing infection control measures.
December 2020
Evaluation of Non-Pharmacological Interventions against COVID-19 and Influenza: Impact Assessment
Non-pharmaceutical interventions, including border restrictions, quarantine, isolation, distancing measures, and behavioral changes, demonstrate effectiveness in reducing transmission of COVID-19 and influenza, highlighting the importance of comprehensive public health strategies to mitigate infectious disease spread.
December 2020
Treatment Guidelines for Patients with COVID-19 Infection: Evidence-Based Recommendations
The Infectious Diseases Society of America (IDSA) develops updated treatment guidelines based on emerging evidence to support healthcare professionals in managing COVID-19 patients, providing evidence-based recommendations for patient care and clinical decision-making.
November 2020
CDC Recommendations for Pharmacies During the COVID-19 Pandemic: Minimizing Risks for Staff and Customers
The CDC provides guidance applicable to all pharmacy staff to mitigate their exposure to SARS-CoV-2 and reduce transmission risks to customers, emphasizing the importance of implementing infection control measures and promoting adherence to public health recommendations.
November 2020
Clinical Characteristics of Children with Coronavirus Disease 2019 (COVID-19)
Analysis of a large cohort of children with COVID-19 reveals milder clinical manifestations compared to adults, with infants and young children being particularly susceptible to infection despite less severe symptoms.
November 2020
Turbulent Gas Clouds and Respiratory Pathogen Emissions: Implications for Disease Transmission
Understanding the transmission dynamics of respiratory infectious diseases, such as COVID-19, is crucial for implementing effective prevention measures. This study investigates the role of turbulent gas clouds in pathogen emissions and transmission, highlighting the urgency of adopting rational and scientific prevention strategies.
November 2020
Community-Acquired Pneumonia: Diagnosis, Treatment, and Infection Prevention
Overview of diagnostic methods, empiric treatment options, and infection prevention strategies for managing patients suspected of having community-acquired pneumonia, offering guidance to healthcare providers in clinical practice.
November 2020
